Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_assertion type Assertion NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_head.
- NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_assertion description "[The present study supports that EB might be considered a systemic inflammatory disease rather than a skin-limited disorder; clinical disease activity scores could be also integrated by laboratory data such as IL-6 and IL-12 dosage; biotherapies targeting specific cytokine networks probably represent a way to go in the future.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_provenance.
- NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_assertion evidence source_evidence_literature NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_provenance.
- NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_assertion SIO_000772 26496255 NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_provenance.
- NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_assertion wasDerivedFrom befree-2016 NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_provenance.
- NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_assertion wasGeneratedBy ECO_0000203 NP1295183.RASn35MFp7M6hN2n6w1lE42-lmkE90A1PQPrqaymwb5oE130_provenance.